特一藥業(002728.SZ):擬以625萬元收購特壹美25%股權 強化以生殖器官整形與修復為核心的醫療美容板塊的戰略佈局
格隆匯5月27日丨特一藥業(002728.SZ)公佈,公司為了抓住健康中國建設的重要機遇,尋找新的經營渠道,促進公司未來持續穩健的發展,由公司大健康產業投資運營平台廣東特美健康科技產業有限公司(“特美健康”)以625萬元人民幣的現金方式受讓瑞黎珠寶(廣州)有限公司(“瑞黎珠寶”)所持有的廣州特壹美醫療美容門診部有限公司(“特壹美”)250萬元出資(佔特壹美註冊資本的25%)。
特壹美成立於2017年10月,目前在廣州和佛山分別設有門診中心。廣州公司旗下設有:醫療美容、整形外科、毛髮移植中心、麻醉科、牙科、檢驗科、美容光電皮膚科、教育培訓中心等,佛山公司(已籌建完成並通過消防驗收,提交的許可審核材料已受理)主設專科私密醫療護理等。特壹美秉承醫學技術是基礎,藝術審美是關鍵的服務宗旨,將醫術、技術與藝術三者完美結合,務求成為東方女性美與健康生活品質的創造者。
瑞黎珠寶、特美健康在簽署上述《股權轉讓協議書》的同時,與特壹美三方同日籤署了《戰略投資框架協議》。
佈局生殖器官整形與功能修復為核心的醫療美容服務終端,打造中國女性私密醫療護理知名連鎖品牌。
特美健康此次擬通過現金收購的方式實現對特壹美25%股權的收購,逐步落地和夯實醫美業務板塊系列佈局。特壹美在醫美行業深耕多年,在生殖器官整形與功能修復擁有國內強大的醫生專家資源,擁有強大的客户資源、技術積累和區域品牌優勢。
此次交易的實施將有助於公司運用資本市場平台整合醫療美容資源,強化以生殖器官整形與修復為核心的醫療美容板塊的戰略佈局,增強公司在醫美領域的影響力,快速佔據行業有利位置。快速切入醫美領域,打造中國女性私密醫療護理引領者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.